Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto:
Schedule
Product: Lemsip Chesty Cough Medicine
Active Ingredient(s): Guaiphenesin 10mg/mL
Dosage Form: Linctus
NZ Sponsor: Reckitt & Colman (New Zealand) Limited
Manufacturer(s): Reckitt & Colman Products Limited, Hull, North Humberside, United Kingdom
Product: NovoRapid NovoLet
Active Ingredient(s): Insulin aspart 100U/mL
Dosage Form: Solution for injection
NZ Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer(s): Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product: NovoRapid Penfill
Active Ingredient(s): Insulin aspart 100U/mL
Dosage Form: Solution for injection
NZ Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer(s): Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product: NovoRapid
Active Ingredient(s): Insulin aspart 100U/mL
Dosage Form: Solution for injection
NZ Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer(s): Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product: Visine Advance Relief
Active Ingredient(s): Tetrahydrozoline hydrochloride 0.05%w/v
Dosage Form: Eye drops, solution
NZ Sponsor: Pfizer Laboratories Limited
Manufacturer(s): Pfizer Laboratories Division Pfizer Inc, Parsippany, New Jersey, United States of America
Dated this 2nd day o February 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).